benzinga.com4 Biotech Stocks That Are Showing Weakness: Momentum Scores Fading Over The Past Week6 days ago
finance.yahoo.comChampions Oncology (NASDAQ:CSBR) Is In A Strong Position To Grow Its Business12 months ago
finance.yahoo.comChampions Oncology Reports Quarterly Revenue of $14.1 Million Adjusted EBITDA of $2.0 Million12 months ago
finance.yahoo.comChampions Oncology to Announce Fourth Quarter and Year-End Financial Results on Thursday, July 18, 2024about 1 year ago
finance.yahoo.comChampions Oncology and Medicines Discovery Catapult Forge Partnership to Accelerate Radiopharmaceutical Therapeutics Developmentover 1 year ago
finance.yahoo.comChampions Oncology (NASDAQ:CSBR) shareholders have endured a 53% loss from investing in the stock three years agoover 1 year ago
simplywall.stIndependent Director of Champions Oncology Daniel Mendelson Buys 14% More Sharesalmost 2 years ago
finance.yahoo.comChampions Oncology, Inc. (NASDAQ:CSBR) Q1 2024 Earnings Call Transcriptalmost 2 years ago
CashuChampions Oncology Navigates Cooling Biotech Sector Amidst Investor Caution and Market Instability4 days ago